Quoin Pharmaceuticals Ltd.

QNRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671502

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 1, 20269:40 PM ETAug 31, 2026Carter Denise P.Chief Operating OfficerPPurchaseADSs+20.49K$4.88+$99.99K37.71K+119.0%SEC
Sep 1, 20269:40 PM ETAug 31, 2026Carter Denise P.Chief Operating OfficerPPurchaseADS · Derivative+10.25K––10.25K–SEC
Sep 1, 20269:39 PM ETAug 31, 2026Myers MichaelChief Executive OfficerPPurchaseADSs+20.49K$4.88+$99.99K37.71K+119.0%SEC
Sep 1, 20269:39 PM ETAug 31, 2026Myers MichaelChief Executive OfficerPPurchaseADS · Derivative+10.25K––10.25K–SEC
Sep 1, 20269:39 PM ETAug 31, 2026Lawlor Sally BridgetChief Financial OfficerPPurchaseADSs+10.24K$4.88+$49.99K10.68K+2,328.2%SEC
Sep 1, 20269:39 PM ETAug 31, 2026Lawlor Sally BridgetChief Financial OfficerPPurchaseADS · Derivative+5.12K––5.12K–SEC
Sep 1, 20269:38 PM ETAug 31, 2026Culverwell Anthony JamesDirectorPPurchaseADSs+6.15K$4.88+$29.99K40.36K+18.0%SEC
Sep 1, 20269:38 PM ETAug 31, 2026Culverwell Anthony JamesDirectorPPurchaseADS · Derivative+3.07K––3.07K–SEC
Oct 15, 2025Oct 14, 2025LANGER DENNISDirectorPPurchaseADSs+15.15K$8.49+$128.64K15.15K+1,515,200.0%SEC
Oct 15, 2025Oct 14, 2025LANGER DENNISDirectorPPurchaseADS · Derivative+60.61K––15.15K–SEC
Dec 27, 20245:17 PM ETDec 23, 2024Carter Denise P.Chief Operating OfficerPPurchaseOrdinary Shares+555.56K$0.45+$250K602.65K+1,179.7%SEC
Dec 27, 20245:17 PM ETDec 23, 2024Carter Denise P.Chief Operating OfficerPPurchaseADS · Derivative+1.11M––555.56K–SEC
Dec 27, 20245:16 PM ETDec 23, 2024Myers MichaelChief Executive OfficerPPurchaseOrdinary Shares+555.56K$0.45+$250K602.81K+1,175.7%SEC
Dec 27, 20245:16 PM ETDec 23, 2024Myers MichaelChief Executive OfficerPPurchaseADS · Derivative+1.11M––555.56K–SEC
Dec 27, 20245:16 PM ETDec 23, 2024Dunn GordonChief Financial OfficerPPurchaseOrdinary Shares+122.22K$0.45+$55K151.08K+423.6%SEC
Dec 27, 20245:16 PM ETDec 23, 2024Dunn GordonChief Financial OfficerPPurchaseADS · Derivative+244.44K––122.22K–SEC
Dec 27, 20245:15 PM ETDec 23, 2024Culverwell Anthony JamesDirectorPPurchaseOrdinary Shares+100K$0.45+$45K100.32K+31,545.7%SEC
Dec 27, 20245:15 PM ETDec 23, 2024Culverwell Anthony JamesDirectorPPurchaseADS · Derivative+200K––100K–SEC
Sep 11, 2024Sep 9 – Sep 10, 2024Dunn GordonChief Financial OfficerPPurchaseOrdinary Shares+28.86K$0.8042+$23.2K28.86KNew positionSEC
Sep 5, 2024Sep 3 – Sep 4, 2024Carter Denise P.Chief Operating OfficerPPurchaseOrdinary Shares+37.74K$0.7649+$28.86K47.09K+403.3%SEC
Sep 5, 2024Sep 3 – Sep 4, 2024Myers MichaelChief Executive OfficerPPurchaseOrdinary Shares+37.89K$0.7657+$29.02K47.25K+404.9%SEC
Jun 10, 2024Jun 7, 2024LANGER DENNISDirectorSSaleOrdinary Shares−297$0.73−$216.8153−84.9%SEC